newsfilter
← Latest News
GlobeNewswire·

BioXcel Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Rule

NEW HAVEN, Conn., Feb. 28, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (NASDAQ:BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today